Emerging evidence suggested that BCLAF1 is involved in the regulation of angiogenesis, cell proliferation, and drug resistance in HCC by activating the transcription of hypoxia-inducible factor-1α (HIF-1α) [22–24]. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.